Samchundang Pharmaceutical Obtains Patent for Ophthalmic Pharmaceutical Composition

[Asia Economy Reporter Eunmo Koo] Samchundang Pharmaceutical announced on the 7th that it has acquired a patent related to an ophthalmic pharmaceutical composition. The company explained the patent as “a technology for an ophthalmic formulation containing aflibercept, a macular degeneration treatment, as an active ingredient, which enables long-term stability of material properties and biological activity under long-term storage and accelerated conditions.”